Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases

Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014

Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation

Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France
Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation ( Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France )
1 Feb 2014

Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA
Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer ( Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA )
31 Jan 2014

MET variant as a prognostic marker in clear cell renal cell carcinoma

Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA
MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 Jan 2014

Results of orteronel plus prednisone in the TAK-700 trial on mCRPC

Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC ( Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA )
31 Jan 2014

Results of the MARS study in renal cell carcinoma

Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France
Results of the MARS study in renal cell carcinoma ( Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France )
31 Jan 2014

Dissecting the biology of the androgen receptor pathway

Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA
Dissecting the biology of the androgen receptor pathway ( Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 Jan 2014

IBM Watson for Healthcare

David Kerr - Director, Watson for Healthcare in the IBM Corporate Strategy team
IBM Watson for Healthcare ( David Kerr - Director, Watson for Healthcare in the IBM Corporate Strategy team )
30 Jan 2014

The future of ontology

Prof Robert Stevens - Professor of Computer Science in the Bio-Health Informatics Group in the School of Computer Science, University of Manchester, U.K.
The future of ontology ( Prof Robert Stevens - Professor of Computer Science in the Bio-Health Informatics Group in the School of Computer Science, University of Manchester, U.K. )
30 Jan 2014

W3C and semantic web tecnology

Charlie Mead - Co-Chair, World Wide Web Consortium (W3C)
W3C and semantic web tecnology ( Charlie Mead - Co-Chair, World Wide Web Consortium (W3C) )
30 Jan 2014

Improving research capabilities with semantic web technology

Kerstin Forsberg - Information architect, AstraZeneca
Improving research capabilities with semantic web technology ( Kerstin Forsberg - Information architect, AstraZeneca )
30 Jan 2014

W3C and maintaining the semantic web platform

Eric Prud'hommeaux - Sanitation engineer, World Wide Web Consortium (W3C)
W3C and maintaining the semantic web platform ( Eric Prud'hommeaux - Sanitation engineer, World Wide Web Consortium (W3C) )
30 Jan 2014